↓ Skip to main content

Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences

Overview of attention for article published in Leukemia & Lymphoma, September 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
twitter
2 X users
reddit
1 Redditor
guideline
1 clinical guideline source

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences
Published in
Leukemia & Lymphoma, September 2016
DOI 10.1080/10428194.2016.1218006
Pubmed ID
Authors
Abstract

Dural lymphoma (DL) is a rare type of primary CNS lymphoma arising from the dura mater. The optimal treatment is uncertain. A retrospective review was performed on 26 DL patients. Seventeen patients underwent resection and nine had a biopsy. Twenty three patients could be assessed for a response to treatment after surgery. Thirteen received focal radiotherapy (RT), six whole brain RT (WBRT), three chemotherapy alone and one chemotherapy followed by WBRT. Twenty two achieved complete response (CR) and one a partial response (PR). Four patients relapsed (two local and two systemic). Median follow up was 64 months, with median progression free survival (PFS) and OS not reached. Three year PFS was 89% (95% CI 0.64-0.97). All patients are alive at last follow-up, demonstrating that DL is an indolent tumor with long survival. CR is achievable with focal therapy in the majority of cases, but there is a risk for relapses and long-term follow-up is recommended.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 7 18%
Student > Doctoral Student 5 13%
Researcher 3 8%
Student > Postgraduate 3 8%
Professor 2 5%
Other 5 13%
Unknown 13 34%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 17 45%
Biochemistry, Genetics and Molecular Biology 2 5%
Arts and Humanities 1 3%
Nursing and Health Professions 1 3%
Neuroscience 1 3%
Other 0 0%
Unknown 16 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2023.
All research outputs
#4,217,565
of 34,492,055 outputs
Outputs from Leukemia & Lymphoma
#277
of 5,268 outputs
Outputs of similar age
#49,418
of 333,608 outputs
Outputs of similar age from Leukemia & Lymphoma
#4
of 56 outputs
Altmetric has tracked 34,492,055 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,268 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,608 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.